Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion.
Aowen Zhuang, Felicia Y. T. Yap, Domenica A. McCarthy, Sherman S. Leung, Sally A. Penfold, Chris Leung, Karly C. Sourris, Brooke E. Harcourt, Vicki Thallas‐Bonke, Melinda T. Coughlan, Benjamin Luke Schulz, Josephine Maree Forbes
This study shows that increasing OST48 expression in diabetic mice improves insulin secretion but does not prevent diabetic kidney disease despite enhancing AGE clearance.
Scientific Reports · Sep 20, 2019Peer-reviewedMolecular Biology